Literature DB >> 2427524

Transcriptional regulation of thyrotropin subunit genes by thyrotropin-releasing hormone and dopamine in pituitary cell culture.

M A Shupnik, S L Greenspan, E C Ridgway.   

Abstract

Thyrotropin (TSH) is an anterior pituitary glycoprotein hormone which modulates thyroid hormone production by the thyroid gland. TSH and its two subunits, TSH beta and alpha-subunit, are in turn regulated by the thyroid hormones and several stimulatory and inhibitory factors produced by the hypothalamus. Hypothalamic hormones such as thyrotropin-releasing hormone (TRH) and dopamine have profound effects on TSH secretion and may also modulate TSH synthesis. We investigated the ability of these two hormones to directly influence the expression of the TSH subunit genes by measuring subunit mRNA synthesis rates in treated and untreated pituitary cell cultures from hypothyroid rats. In this system, basal rates of mRNA synthesis were similar for the two subunits, with 95 ppm for alpha-subunit and 85 ppm for TSH beta. Treatment with 10(-5) M dopamine, an inhibitor of TSH secretion, decreased both alpha-subunit and TSH beta mRNA synthesis within 15 min, and maximal decreases of approximately 75% for both subunits were obtained after 30 min. The inhibitory effects of dopamine were overcome by co-incubation of the cells with dopamine plus 5 X 10(-4) M dibutyryl cyclic AMP (cAMP), indicating that the actions of dopamine may have been mediated by decreasing intracellular cAMP levels. Treatment with 10(-7) M TRH, a potent stimulator of TSH secretion, increased transcription of both TSH subunit genes 3- to 5-fold. Maximal stimulation occurred after 30 min of treatment; however, 2-fold increases were maintained for up to 4 h and at 48 h. Cytoplasmic levels of TSH beta and alpha-subunit mRNA after 48 h were also depressed by dopamine (50-70%) and increased by TRH (200-280%) treatment. TRH-stimulated TSH beta and alpha-subunit mRNA synthesis was partially inhibited by dopamine. In a 4-h treatment period, TSH beta mRNA synthesis was decreased from 250 to 73% of control and alpha-subunit was decreased from 333 to 182% of control values. Thus, both dopamine and TRH can act to modulate TSH subunit gene transcription, although they differ in the direction of the response and the relative effects on TSH beta and alpha-subunit. The magnitude of the transcriptional response for either TRH (200 to 500%) or dopamine (75%) is similar to the observed changes in cytoplasmic levels of TSH subunit mRNAs and indicates that transcriptional control of the TSH genes may be an important component of hypothalamic regulation of TSH.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2427524

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Thyroid function in very low birthweight infants after intravenous administration of the iodinated contrast medium iopromide.

Authors:  J Dembinski; V Arpe; M Kroll; G Hieronimi; P Bartmann
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-05       Impact factor: 5.747

2.  Cocaine decreases expression of neurogranin via alterations in thyroid receptor/retinoid X receptor signaling.

Authors:  Jane Kovalevich; Gladys Corley; William Yen; Jae Kim; Scott M Rawls; Dianne Langford
Journal:  J Neurochem       Date:  2012-03-13       Impact factor: 5.372

3.  trans-acting factors interact with a cyclic AMP response element to modulate expression of the human gonadotropin alpha gene.

Authors:  J L Jameson; P J Deutsch; G D Gallagher; R C Jaffe; J F Habener
Journal:  Mol Cell Biol       Date:  1987-09       Impact factor: 4.272

4.  Plasma GH responses to GHRH, arginine, L-dopa, pyridostigmine, sequential administrations of GHRH and combined administration of PD and GHRH in Turner's syndrome.

Authors:  K Hanew; A Tanaka; A Utsumi
Journal:  J Endocrinol Invest       Date:  1998-02       Impact factor: 4.256

5.  Bromocriptine reduces rat thyrotropin beta-subunit mRNA stability.

Authors:  A Levy; S L Lightman
Journal:  J Endocrinol Invest       Date:  1990-01       Impact factor: 4.256

6.  The transcription factor prolactin regulatory element-binding protein mediates prolactin transcription induced by thyrotropin-releasing hormone in GH3 cells.

Authors:  Xiao Yu; Koji Murao; Hitomi Imachi; Junhua Li; Takamasa Nishiuchi; Hiroaki Dobashi; Naohisa Hosomi; Hisashi Masugata; Guo-Xing Zhang; Hisakazu Iwama; Toshihiko Ishida
Journal:  Endocrine       Date:  2010-05-05       Impact factor: 3.633

7.  Effects of acute ethanol administration and cold exposure on the hypothalamic-pituitary-thyroid axis.

Authors:  R T Zoeller; A Simonyi; O Butnariu; D L Fletcher; P K Rudeen; S McCrone; S L Petersen
Journal:  Endocrine       Date:  1995-01       Impact factor: 3.633

8.  Loss of basal and TRH-stimulated Tshb expression in dispersed pituitary cells.

Authors:  Paula Bargi-Souza; Marek Kucka; Ivana Bjelobaba; Melanija Tomić; Marija M Janjic; Maria Tereza Nunes; Stanko S Stojilkovic
Journal:  Endocrinology       Date:  2015-01       Impact factor: 4.736

Review 9.  Imbalance between thyroid hormones and the dopaminergic system might be central to the pathophysiology of restless legs syndrome: a hypothesis.

Authors:  Jose Carlos Pereira; Marcia Pradella-Hallinan; Hugo de Lins Pessoa
Journal:  Clinics (Sao Paulo)       Date:  2010-05       Impact factor: 2.365

10.  Lack of effect of the dopamine D1 antagonist, NNC 01-0687, on unstimulated and stimulated release of anterior pituitary hormones in males.

Authors:  E Grodum; M Andersen; J Hangaard; O Koldkjaer; C Hagen
Journal:  J Endocrinol Invest       Date:  1998-05       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.